威訊控股(01087.HK)完成配售1404萬股 淨籌1683萬港元
格隆匯9月6日丨威訊控股(01087.HK)宣佈,配售事項的所有條件已全部達成。按照配售協議的條款及條件,配售事項於2021年9月6日完成。配售代理根據配售協議的條款及條件,成功以每股配售股份1.24港元的配售價向不少於六名承配人配售合共1404萬股配售股份(相當於緊隨完成後經配發及發行配售股份擴大後,公司已發行股本約16.67%)。
配售事項的所得款項淨額(經扣除配售佣金及配售事項的其他相關成本及開支後)為約1683萬港元,將按配售公吿及補充公吿所載用途運用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.